[Clinical significance of risedronate for patients with prostate cancer receiving androgen deprivation therapy].
Kimura M, Satoh T, Okazaki M, Tabata K, Tsuboi T, Hyodo T, Yokoyama E, Matsumoto K, Soh S, Iwamura M, Hayakawa K, Bab S.
Kimura M, et al. Among authors: tsuboi t.
Nihon Hinyokika Gakkai Zasshi. 2008 Jan;99(1):22-8. doi: 10.5980/jpnjurol1989.99.22.
Nihon Hinyokika Gakkai Zasshi. 2008.
PMID: 18260344
Free article.
Japanese.